-
What Makes Mylan's Newest EpiPen Lawsuit Different?
Monday, April 10, 2017 - 2:01pm | 900Mylan N.V. (NASDAQ: MYL), which has faced a plethora of lawsuits in the past over its EpiPen, is now being saddled with another lawsuit, although this time around the parties involved go beyond the company and the plaintiffs. EpiPen And Its Legal Tussle EpiPen, or an epinephrine auto injector is...
-
The Difference Between Mylan's EpiPen And Generic Offerings
Thursday, January 12, 2017 - 5:01pm | 476Mylan NV (NASDAQ: MYL) made headlines in 2016 after patients and politicians denounced the inaccessible prices of its branded EpiPen. On Wednesday, the business took another hit as CIGNA Corporation (NYSE: CI) dropped the branded drug from its coverage. Cigna will cover Mylan’s $300 generic...
-
A Cheaper Option To The EpiPen
Wednesday, August 24, 2016 - 4:57pm | 350Mylan NV (NASDAQ: MYL) has been in the spotlight this week after the company substantially increased its EpiPen prices. This led to criticism from presidential candidate Hillary Clinton and the White House Meanwhile, further controversy emerged on the back of disproportionate executive salary...